The agency is proposing allowing other tastes for vapes, like mint, coffees, spices or tea, to appeal to adults. At the same time, illicit candy-flavored types aimed at teenagers have flooded the market.
Category: Makary, Marty
-
F.D.A. Opens Door to More Flavored E-Cigarettes
The New York Times – Business: -
U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine
The New York Times – Business:The F.D.A.’s refusal to examine the company’s mRNA shot drew widespread criticism from doctors and was divisive within the agency.
-
F.D.A. Turmoil Keeps Spotlight on Its Commissioner
The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership of Dr. Marty Makary.
-
F.D.A.’s Approval of Drug for Autism Upends Review Process
The agency revived an old treatment for cancer patients, unilaterally approving it for a subset of people with autism. Experts worry that the narrower scope will get lost in the hype.
-
F.D.A. Reviews Cases of Covid Vaccine Deaths
The agency plans to present accounts of deaths involving children and birth defects to an influential C.D.C. panel meeting next week.
-
F.D.A. Approves Covid Shots With New Restrictions
The agency’s fall recommendations underscore the goals of Health Secretary Robert F. Kennedy Jr. to limit access to the vaccines, which he has long opposed.
-
Top F.D.A. Official Overrode Scientists on Covid Shots
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.
-
F.D.A. Looks to A.I. to Enhance Efficiency
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.
-
U.S. Will No Longer Recommend Covid Shots for Children and Pregnant Women
Health Secretary Robert F. Kennedy Jr. announced that the vaccine would not be included as part of the immunization schedule for healthy children.
-
F.D.A. Scientists Are Reinstated at Agency Food Safety Labs
After 20 percent of the agency’s work force was cut, federal health officials have decided to bring back some experts and review firings to fill gaps in critical roles.
-
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.